Selected article for: "fold activity and luciferase activity"

Author: Chunxi Zeng; Xucheng Hou; Jingyue Yan; Chengxiang Zhang; Wenqing Li; Weiyu Zhao; Shi Du; Yizhou Dong
Title: Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivo
  • Document date: 2020_4_5
  • ID: aju2nr9x_19
    Snippet: Based on the encouraging cell results, we performed intramuscular (i.m.) injection, a widely used administration route for vaccines 43 , of NASAR mRNAs. Similar to in vitro results, NASAR was 4.2-fold more potent than CYBA in the luciferase expression when both were delivered by TT3 nanoparticles (Supplementary Fig. 5) . Moreover, TT3 nanoparticles induced over 70-fold more luciferase activity than MC3 nanoparticles, an FDA-approved delivery vehi.....
    Document: Based on the encouraging cell results, we performed intramuscular (i.m.) injection, a widely used administration route for vaccines 43 , of NASAR mRNAs. Similar to in vitro results, NASAR was 4.2-fold more potent than CYBA in the luciferase expression when both were delivered by TT3 nanoparticles (Supplementary Fig. 5) . Moreover, TT3 nanoparticles induced over 70-fold more luciferase activity than MC3 nanoparticles, an FDA-approved delivery vehicle 44, 45 , when formulated with the same NASAR mRNAs (Fig. 5c) . Lastly, NASAR mRNAs encoding either RBD or S protein were formulated with TT3 and injected intramuscularly into hind legs of mice. Confocal microscopy imaging of the mouse tissues with immunostaining confirmed the expression of both antigens (Fig. 5d) .

    Search related documents:
    Co phrase search for related documents
    • administration route and intramuscular injection: 1, 2, 3, 4, 5, 6, 7
    • administration route and luciferase activity: 1
    • administration route and luciferase expression: 1
    • delivery vehicle and intramuscular injection: 1
    • delivery vehicle and luciferase expression: 1
    • luciferase expression and microscopy imaging: 1
    • microscopy imaging and mouse tissue: 1